Anti-Aging drug sirolimus put to the test in seniors
NCT ID NCT06727305
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing the drug sirolimus in 60 healthy adults aged 65 and older to see how the body processes it and how it affects aging-related markers. Participants take sirolimus tablets daily for several weeks, with dose adjustments to reach a target blood level. The goal is to gather essential data for future trials that might use sirolimus to slow aging and prevent chronic diseases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Sirolimus (oral tablet)
What this could lead to
If successful, this study could provide the necessary data to design larger trials testing whether sirolimus can slow aging and prevent age-related diseases.
What could go wrong
This is an early-phase study with only 60 participants, focused on measuring drug levels and markers, not on proving any anti-aging benefit. The results may not lead to a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UT Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••